Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 7 of the 104 references it cites were found in a registry or an index, and 97 are not checked yet.

Differential task-related fMRI effects of a single dose of guanfacine and lisdexamfetamine in youth with ADHD: a randomised, double-blind, placebo-controlled crossover study

Open access

Abstract

Background: Stimulant and non-stimulant medications increase fronto-striato-thalamic activation in youth with Attention-Deficit/Hyperactivity Disorder (ADHD). However, comparative effects of the more recently licensed stimulant lisdexamfetamine and non-stimulant guanfacine on functional magnetic resonance imaging (fMRI) correlates in ADHD are unknown. Methods: This exploratory randomised, placebo-controlled, double-blind, crossover study compared fMRI activation in youth with ADHD during a tracking stop-signal task (SST; N = 12), a working memory task (N-back; N = 11) and a sustained attention task (SAT; N = 10), after single clinical doses of either guanfacine extended-release, lisdexamfetamine, or placebo, with one-week washouts. Twenty-one demographically matched typically developing controls (TD) were assessed once to test for potential normalisation of case-control activation differences. Results: Region of interest analysis showed increased right caudate and putamen activation for lisdexamfetamine versus placebo during N-back and SAT, respectively. Both drugs shared an increase in left superior temporal activation versus placebo during N-back. In whole-brain analyses only lisdexamfetamine increased precuneus/posterior cingulate activation during SST versus guanfacine, and during N-back in pre- and postcentral and occipital cortices versus placebo. During SST, placebo-treated ADHD versus TD showed reduced putamen, insula, parietal and occipital activation that was potentially attenuated/normalised under lisdexamfetamine, while under guanfacine lingual gyrus underactivation remained, with additional precuneus and middle temporal underactivation. Also, only lisdexamfetamine improved and normalised SST performance. Conclusion: Lisdexamfetamine appears to have stronger and drug-exclusive upregulation and potential attenuation/normalisation effects than guanfacine on basal ganglia, posterior parieto-occipital and sensorimotor activations during ADHD-relevant executive function tasks with some shared putamen and superior temporal effects.

Overview

Integrity signals

Registry

Crossref · 10.64898/2026.10.01.26364506

Cites

7 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 104 references

Cited by

Still being checked.

Metadata

Authors
El Masri, S., Kowalczyk, O. S., Criaud, M., Lukito, S., Mazibuko, N., Salazar de Pablo, G., Perez-Rodriguez, V., Makos, O., Lam, S.-L., Westwood, S., Eaton-Turner, A., Bozhilova, N., Conti, A. A., Stephenson, S., Rogdaki, M., Adamo, N., Johansson, L., Ougrin, D., Almowasi, F., Santosh, P., Roessner, V., Kohls, G., Mehta, M. A., & Rubia, K.
Affiliations
  • Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
  • King's College London (GB)
  • Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
  • Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
  • Queen Mary University of London (GB)
  • Technische Universität Dresden (DE)
  • Heidelberg University (DE)
Venue
medRxiv
Publisher
openRxiv
Published
2026-10-02
OpenAlex
W7216448619
Cited by
0
References
104
Type
posted content
Language
en
Open access
Locations
medRxiv (acceptedVersion, cc-by)
Funders
  • Takeda Pharmaceuticals International AG (IISR-2016-104081)
  • NIHR Biomedical Research Centre: Maudsley
  • Medical Research Council (MR/P012647/1, APP32868)
  • Efficacy and Mechanism Evaluation programme (NIHR130077, NIHR203684)
  • Medical Research Foundation (MRF-176-0002-RG-FLOH-C0929)
  • Rosetrees Foundation (3442198)
  • Deutsche Forschungsgemeinschaft (DFG) / German Research Foundation (GRK2773/1-454245598)
  • Federal Ministry of Education and Research (BMBF; now: BMFTR) and Ministry of Science, Research and Arts of Baden-WM-CM-<rttemberg
  • National Institute for Health and Care Research (NIHR207448)
  • National Health Service
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
attention deficit hyperactivity disorder, guanfacine, lisdexamfetamine, brain activation, stop-signal task, sustained attention, caudate nucleus, putamen, basal ganglia, precuneus, executive function, youth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential task-related fMRI effects of a single dose of guanfacine and lisdexamfetamine in youth with ADHD: a randomised, double-blind, placebo-controlled crossover study. https://app.cochat.ai/papers/10.64898/2026.10.01.26364506
The paper
El Masri, S., Kowalczyk, O. S., Criaud, M., Lukito, S., Mazibuko, N., Salazar de Pablo, G., Perez-Rodriguez, V., Makos, O., Lam, S.-L., Westwood, S., Eaton-Turner, A., Bozhilova, N., Conti, A. A., Stephenson, S., Rogdaki, M., Adamo, N., Johansson, L., Ougrin, D., Almowasi, F., . . . Rubia, K. (2026). Differential task-related fMRI effects of a single dose of guanfacine and lisdexamfetamine in youth with ADHD: a randomised, double-blind, placebo-controlled crossover study. medRxiv. https://doi.org/10.64898/2026.10.01.26364506

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.